Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA)
EGXTenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
What Changed
Full IR Briefing →Company Overview
Leadership team data not yet available for this company.
We're expanding our GCC coverage — check back soon.
Recent Announcements
No announcements yet.
Data Sources
See Data Freshness Monitor for platform-wide data quality.
Price Chart
Key Metrics
Governance Score
Insufficient data
0/12 dimensions populated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
Frequently Asked Questions about Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda
Where is Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda listed?
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda is listed on the Egyptian Exchange (EGX) in Egypt under the ticker RMDA. SouqData profiles its financials, board and shareholders from public exchange disclosures.
What sector is Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda in?
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (EGX: RMDA) is classified in the Health Technology sector. This classification is what SouqData uses for its sector rankings and peer comparisons.
What is the market cap of Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda?
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (EGX: RMDA) has a market capitalisation of about $161M (USD), according to the latest market data held by SouqData. The figure moves daily with the share price.
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda vs sector peers
Health Technology · small-cap · 5 peers shown| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) | $161M | 1.97% | — | Non-compliant |
| Egyptian International Pharmaceutical Industries Co. (PHAR · EGX) | $264M | — | — | — |
| Minapharm Pharmaceuticals (MIPH · EGX) | $106M | 0.53% | — | Non-compliant |
| El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH · EGX) | $96M | 2.07% | — | Non-compliant |
| Kahira Pharmaceuticals & Chemical Industries Co. (CPCI · EGX) | $81M | 6.08% | — | — |
| Alexandria Company for Pharmaceuticals and Chemical Industries (AXPH · EGX) | $80M | 7.76% | — | — |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 10 sector peers.
Unlock the full SouqData platform
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.